Publications Page Hero Image

Our industry-recognized Education team is committed to sharing program findings, best practices, insights, and trends from our educational programs across a range of therapeutic areas. These findings are regularly published in peer-reviewed journals, as well as presented at medical, patient, and industry conferences.

Lessons Learned by Tracking Educational Program Outcomes

PlatformQ Health is known for its outcomes-driven education. At this year’s European Conference on Rare Diseases, we co-presented two posters highlighting outcomes and lessons learned from recent programming.   Rare disease education  People with rare diseases often wait years for a correct diagnosis. Ongoing education of clinicians and the general public...

Understanding the Impact of CME on Participant Knowledge and Behavior

Using Gene Therapy to Treat Duchenne Muscular Dystrophy The first FDA-approved gene therapy for pediatric patients with Duchenne muscular dystrophy (DMD) is now available. This is a genetic disorder that presents as progressive muscle degeneration and weakness. A live CME activity was held to educate clinicians about this newly available...

Uncovered Barriers to Clinical Trial Enrollment Among Patients with Non-Hodgkin’s Lymphoma

Clinical trials are crucial for advancing care for non-Hodgkin's lymphoma (NHL), however, accrual in these studies remains low. To address this issue, PlatformQ Health, the Leukemia & Lymphoma Society, BlackDoctor.org, and Partners for Advancing Clinical Education co-produced the BUILD-NHL Trial Equity Initiative.  The goal was to reduce disparities in trial...

Driving Equitable Healthcare through Patient and Provider Education

PlatformQ Health, the Asthma and Allergy Foundation of America (AAFA), and BlackDoctor.org were seeking to understand whether aligned (sequential patient/provider) education could help improve health equity for those suffering from conditions such as asthma and atopic dermatitis. Black people with asthma are more likely to succumb to asthma than White...

Program Outcomes Demonstrate High Need for Immunotherapy Education

[vc_row][vc_column][vc_column_text]Immunotherapy is increasingly being used to treat patients with melanoma and other types of cancer. Management of these therapies differs distinctly from previous standard-of-care options such as chemotherapy. Optimizing care involves educating a multidisciplinary healthcare team about therapy management as well as educating patients about therapies and the factors that...

High Need for Patient and Provider Education Amid Approval of Anti-FcRn Agents and C5 Inhibitors

[vc_row][vc_column][vc_column_text]In the wake of FDA approvals for treating myasthenia gravis (gMG, healthcare providers have the ability to individualize treatment. As these new therapies become adopted, it's crucial to educate patients and providers about issues such as disease presentation, comorbidities, and patient preferences that may impact treatment decisions. To support patients...

Educational Initiatives in gMG, DMD and SMA

Aligned Education Improves Patient Outcomes Across CME Programs As the treatment landscape for neuromuscular physiology and diseases evolves, PlatformQ Health has been at the forefront of patient and provider education, delivering programming that drives improved patient experiences and shared decision making. Numerous posters of educational outcomes have been published at...